{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:28:03Z","timestamp":1787761683129,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>ABSTRACT<\/jats:title>\n                    <jats:p>Topical minoxidil is used for treating different hair disorders. Even though it is an effective therapy, many patients show poor compliance due to the cost, side effects, and duration of treatment. Topical minoxidil is the mainstay treatment for androgenetic alopecia (AGA). Recently, low alcohol or alcohol-free topical minoxidil formulation has proven to be an alternative for patients suffering from AGA, including those with poor compliance with other therapies. Thus, the current article provides the positioning of low alcohol or alcohol-free topical minoxidil to manage AGA in Indian clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_54_22","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:23:59Z","timestamp":1681950239000},"page":"13-17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Positioning of Low Alcohol or Alcohol-Free Minoxidil Formulation for the Management of Androgenetic Alopecia"],"prefix":"10.4103","volume":"15","author":[{"given":"Satish","family":"Udare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. R.","family":"Dayananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas Ranjan","family":"Puhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Ramanbhai","family":"Gamit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Karthik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monil Yogesh","family":"Neena Gala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Muchhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240903","first-page":"15","article-title":"Androgenetic alopecia","volume":"149","author":"Piraccini","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"key":"R2-3-20240903","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","article-title":"Minoxidil: A comprehensive review","volume":"33","author":"Gupta","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"R3-3-20240903","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0974-7753.58556","article-title":"Male androgenetic alopecia: Population-based study in 1,005 subjects","volume":"1","author":"Krupa Shankar","year":"2009","journal-title":"Int J Trichology"},{"key":"R5-3-20240903","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/ijt.ijt_6_19","article-title":"Quality of life assessment in patients with androgenetic alopecia","volume":"11","author":"Gupta","year":"2019","journal-title":"Int J Trichology"},{"key":"R6-3-20240903","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"key":"R7-3-20240903","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00005344-198000022-00002","article-title":"Pharmacology and pharmacokinetics of minoxidil","volume":"2","author":"Lowenthal","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"R8-3-20240903","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"R9-3-20240903","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/ijt.ijt_24_19","article-title":"Expert consensus on the management of androgenetic alopecia in India","volume":"11","author":"Mysore","year":"2019","journal-title":"Int J Trichology"},{"key":"R10-3-20240903","doi-asserted-by":"crossref","first-page":"287","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20220503","article-title":"Optimal use of topical minoxidil in management of female pattern hair loss in India: An expert opinion","volume":"8","author":"Mysore","year":"2022","journal-title":"Int J Res Dermatol"},{"key":"R11-3-20240903","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men \u2013 Short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-3-20240903","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jdv.12034","article-title":"Guidelines for management of androgenetic alopecia based on BASP classification \u2013 The Asian Consensus Committee Guideline","volume":"27","author":"Lee","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-3-20240903","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1346-8138.14470","article-title":"Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version","volume":"45","author":"Manabe","year":"2018","journal-title":"J Dermatol"},{"key":"R14-3-20240903","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jocd.12541","article-title":"Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study","volume":"18","author":"Blume-Peytavi","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"R15-3-20240903","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13555-020-00374-y","article-title":"comparative study to evaluate tolerability of topical 5% minoxidil novel formulation and alcohol-based conventional solutions in treatment of androgenetic alopecia in Indian men: Randomized double-blind study","volume":"10","author":"Sarkar","year":"2020","journal-title":"Dermatol Ther (Heidelb"},{"key":"R17-3-20240903","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1067\/mjd.2002.119104","article-title":"Allergic contact dermatitis to topical minoxidil solution: Etiology and treatment","volume":"46","author":"Friedman","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R18-3-20240903","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R19-3-20240903","doi-asserted-by":"crossref","first-page":"341","DOI":"10.23736\/S0392-0488.20.06554-2","article-title":"Propylene glycol free 5% minoxidil lotion formulation: Cosmetic acceptability, local tolerability, clinical efficacy and in-vitro skin absorption evaluations","volume":"155","author":"Barbareschi","year":"2020","journal-title":"G Ital Dermatol Venereol"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_54_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:02:42Z","timestamp":1787760162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_54_22"}},"subtitle":["Indian Perspective"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_54_22","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}